Bgm (BGM) Cash & Current Investments (2019 - 2025)
Bgm's (BGM) quarterly Cash & Current Investments came in at $9.8 million in Q3 2025, down 15.96% year-on-year from $11.7 million in Q3 2024, and up 12.11% on a QoQ basis from $8.8 million in Q1 2025.
Bgm (BGM) Cash & Current Investments (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Cash & Current Investments data on file, last reported at $9.8 million in Q3 2025.
- On a quarterly basis, Cash & Current Investments fell 15.96% year-over-year to $9.8 million in Q3 2025; TTM through Sep 2025 was $9.8 million, a 15.96% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 15.96% from the prior year.
- Cash & Current Investments for Q3 2025 stood at $9.8 million, up from $8.8 million in the prior quarter.
- Over the last five years, Cash & Current Investments for BGM reached as high as $20000.0 billion in Q1 2021 and fell as low as $8.5 million in Q3 2023.
- Historically, Cash & Current Investments has averaged $2578.4 billion across 5 years, with a median of $12.1 million in 2021.
- On a YoY basis, Cash & Current Investments climbed as much as 37.86% in 2024 and fell as far as 100.0% in 2024.
- Year by year, Cash & Current Investments stood at $12.6 million in 2021, then grew by 18.81% to $15.0 million in 2022, then tumbled by 43.41% to $8.5 million in 2023, then surged by 37.86% to $11.7 million in 2024, then decreased by 15.96% to $9.8 million in 2025.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $9.8 million in Q3 2025, $8.8 million in Q1 2025, and $11.7 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 3.74 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 1.94 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 4.06 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 2.15 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 1.80 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.32 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 428.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - | 9.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.82 Mn |
| Mar 31, 2025 | 8.76 Mn |
| Sep 30, 2024 | 11.69 Mn |
| Mar 31, 2024 | 10.79 Mn |
| Sep 30, 2023 | 8.48 Mn |
| Mar 31, 2023 | 834.49 Bn |
| Sep 30, 2022 | 14.98 Mn |
| Mar 31, 2022 | 4,949.63 Bn |
| Sep 30, 2021 | 12.61 Mn |
| Mar 31, 2021 | 20,000.00 Bn |
| Sep 30, 2020 | 11.87 Mn |
| Sep 30, 2019 | 4.59 Mn |